188 related articles for article (PubMed ID: 3772387)
1. Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.
Flynn DD; Mash DC
J Neurochem; 1986 Dec; 47(6):1948-54. PubMed ID: 3772387
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic acetylcholine binding sites in Alzheimer's disease.
Whitehouse PJ; Martino AM; Antuono PG; Lowenstein PR; Coyle JT; Price DL; Kellar KJ
Brain Res; 1986 Apr; 371(1):146-51. PubMed ID: 3708340
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
Sihver W; Gillberg PG; Svensson AL; Nordberg A
Neuroscience; 1999; 94(3):685-96. PubMed ID: 10579560
[TBL] [Abstract][Full Text] [Related]
5. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
[TBL] [Abstract][Full Text] [Related]
6. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
Lange KW; Wells FR; Jenner P; Marsden CD
J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
[TBL] [Abstract][Full Text] [Related]
7. Reductions in acetylcholine and nicotine binding in several degenerative diseases.
Whitehouse PJ; Martino AM; Marcus KA; Zweig RM; Singer HS; Price DL; Kellar KJ
Arch Neurol; 1988 Jul; 45(7):722-4. PubMed ID: 3390025
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain.
Lapchak PA; Araujo DM; Quirion R; Collier B
J Neurochem; 1989 Feb; 52(2):483-91. PubMed ID: 2911027
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.
London ED; Ball MJ; Waller SB
Neurochem Res; 1989 Aug; 14(8):745-50. PubMed ID: 2812250
[TBL] [Abstract][Full Text] [Related]
10. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.
Nordberg A; Winblad B
Neurosci Lett; 1986 Dec; 72(1):115-9. PubMed ID: 3808458
[TBL] [Abstract][Full Text] [Related]
11. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
Perry EK; Smith CJ; Court JA; Perry RH
J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.
Slotkin TA; Nemeroff CB; Bissette G; Seidler FJ
J Clin Invest; 1994 Aug; 94(2):696-702. PubMed ID: 8040324
[TBL] [Abstract][Full Text] [Related]
14. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
[TBL] [Abstract][Full Text] [Related]
15. Chronic estradiol treatment alters central cholinergic function in the female rat: effect on choline acetyltransferase activity, acetylcholine content, and nicotinic autoreceptor function.
Lapchak PA; Araujo DM; Quirion R; Beaudet A
Brain Res; 1990 Aug; 525(2):249-55. PubMed ID: 2253030
[TBL] [Abstract][Full Text] [Related]
16. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
Aubert I; Araujo DM; Cécyre D; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1992 Feb; 58(2):529-41. PubMed ID: 1729398
[TBL] [Abstract][Full Text] [Related]
17. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.
Whitehouse PJ; Martino AM; Wagster MV; Price DL; Mayeux R; Atack JR; Kellar KJ
Neurology; 1988 May; 38(5):720-3. PubMed ID: 3362368
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.
Sugaya K; Giacobini E; Chiappinelli VA
J Neurosci Res; 1990 Nov; 27(3):349-59. PubMed ID: 2097379
[TBL] [Abstract][Full Text] [Related]
19. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease.
Rinne JO; Myllykylä T; Lönnberg P; Marjamäki P
Brain Res; 1991 Apr; 547(1):167-70. PubMed ID: 1860068
[TBL] [Abstract][Full Text] [Related]
20. Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease.
Sorbi S; Piacentini S; Amaducci L
Gerontology; 1987; 33(3-4):197-202. PubMed ID: 3653702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
